Immune augmentation of single contact hepatitis B vaccine by using PLGA microspheres as an adjuvant

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 4, 2008, Pages 487-490

  Sivakumar, S ^a   Sukumaran, N ^b   Murugesan, R ^c   Shanmugarajan, T ^a   Anbu, J ^a   Sivakumar, L ^a   Anilbabu, B ^a   Srinivasarao, G ^a   Ravichandran, V ^a  

^a VELS INSTITUTE OF SCIENCE   (India)

^b MANONMANIAM SUNDARANAR UNIVERSITY   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

Author keywords

Adjuvant; Hepatitis B vaccine delivery; Immune augmentation; PLGA microspheres

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICROSPHERE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HEPATITIS B; MALE; MICROENCAPSULATION; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPE; SINGLE DRUG DOSE; VACCINATION; VACCINE PRODUCTION;

EID: 58149091312     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.44599     Document Type: Article

References (8)

1. Leifeld L, Cheng S, Ramakers J, Dumoulin FL, Trautwein C, Sauerbruch T, et al. Imbalanced intra hepatic expression of Interleukin 12, interferon gamma and interleukin 10 in fulminant hepatitis B. Hepatology 2002;36:1001-8.
2. Kane MA. Global status of hepatitis B immunisation. Lancet 1996;348:696.
3. Lok AS, Wu PC, Lai CL, Lau JY, Leung EK, Wong LS, et al. A controlled trial of interferon with or without prednisone priming for hepatitis B. Gastroenterology 1992;102:2091-7.
4. Alexander GJ, Brahm J, Fagan EA, Smith HM, Daniels HM, Eddleston AL, et al. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987;2:66-9.
5. Expanded Programme on Immunization, Weekly Epidemiological Record. Part 1. WHO Publication; 1992. p. 11-5.
6. van der Lubben IM, Gideon K, Fretz MM, Beuvery CJ, Coos V, Junginger HE. Chitosan microparticles for mucosal vaccination against diphtheria: Oral and nasal efficacy studies in mice. Vaccine 2003;21:1400-8.
7. Alonso MJ, Alejandro S, Belen V, Yuyi G, McIver J. Formulation strategies for the stabilization of tetanus toxoid in poly (DL-lactide-co-glycolide) microsphere. Int J Pharm 1999;185:255-66.
8. Aguado MT. Future approaches to vaccine development: Single-dose vaccines using controlled-release delivery systems. Vaccine 1993;11:596-7.